[go: up one dir, main page]

NO933647L - Karboksylsyrederivater, legemidler inneholdende disse og fremgangsmåte for deres fremstilling - Google Patents

Karboksylsyrederivater, legemidler inneholdende disse og fremgangsmåte for deres fremstilling

Info

Publication number
NO933647L
NO933647L NO933647A NO933647A NO933647L NO 933647 L NO933647 L NO 933647L NO 933647 A NO933647 A NO 933647A NO 933647 A NO933647 A NO 933647A NO 933647 L NO933647 L NO 933647L
Authority
NO
Norway
Prior art keywords
preparation
methods
carboxylic acid
acid derivatives
drugs containing
Prior art date
Application number
NO933647A
Other languages
English (en)
Other versions
NO180232B (no
NO933647D0 (no
NO180232C (no
Inventor
Helmut Pieper
Gunter Linz
Frank Himmelsbach
Volkhard Austel
Thomas Muller
Hans Weisenberger
Brian Guth
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO933647D0 publication Critical patent/NO933647D0/no
Publication of NO933647L publication Critical patent/NO933647L/no
Publication of NO180232B publication Critical patent/NO180232B/no
Publication of NO180232C publication Critical patent/NO180232C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO933647A 1992-10-12 1993-10-11 Karboksylsyrederivater, legemidler inneholdende disse, og anvendelse av disse for fremstilling av legemidler NO180232C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4234295A DE4234295A1 (de) 1992-10-12 1992-10-12 Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Publications (4)

Publication Number Publication Date
NO933647D0 NO933647D0 (no) 1993-10-11
NO933647L true NO933647L (no) 1994-04-13
NO180232B NO180232B (no) 1996-12-02
NO180232C NO180232C (no) 1997-03-12

Family

ID=6470224

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933647A NO180232C (no) 1992-10-12 1993-10-11 Karboksylsyrederivater, legemidler inneholdende disse, og anvendelse av disse for fremstilling av legemidler

Country Status (19)

Country Link
US (1) US5442064A (no)
EP (1) EP0592949A3 (no)
JP (1) JPH06199788A (no)
KR (1) KR940009164A (no)
CN (1) CN1087904A (no)
AU (1) AU668765B2 (no)
CA (1) CA2108093A1 (no)
CZ (1) CZ212893A3 (no)
DE (1) DE4234295A1 (no)
FI (1) FI934460A7 (no)
HU (1) HU9302875D0 (no)
IL (1) IL107221A0 (no)
MX (1) MX9306303A (no)
NO (1) NO180232C (no)
NZ (1) NZ248894A (no)
PL (1) PL300673A1 (no)
SK (1) SK107293A3 (no)
TW (1) TW293815B (no)
ZA (1) ZA937502B (no)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL116893A (en) * 1995-02-10 2000-02-29 Yamanouchi Pharma Co Ltd Piperazine derivatives and pharmaceutical compositions containing them
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
WO1997002245A1 (en) * 1995-07-06 1997-01-23 Japan Tobacco Inc. Benzamidoxime derivatives and medicinal use thereof
DE19652919A1 (de) * 1996-12-19 1998-06-25 Solvay Pharm Gmbh Piperazinophenyl- und Piperazinophenyloxy-carbonsäure-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US6162629A (en) * 1997-04-28 2000-12-19 Eli Lilly And Company Methods for processing activated protein C
US6630137B1 (en) * 1997-04-28 2003-10-07 Eli Lilly And Company Activated protein C formulations
DE19743435A1 (de) * 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
FR2781220B1 (fr) * 1998-07-17 2000-10-13 Lafon Labor Piperazinones substituees en beta
PL346795A1 (en) 1998-09-22 2002-02-25 Yamanouchi Pharma Co Ltd Cyanophenyl derivatives
JP4903963B2 (ja) * 1999-11-08 2012-03-28 シェーリング コーポレイション Ｎ−（４−ヒドロキシ−フェニル）−ｎ’−（４’−アミノフェニル）−ピペラジンを調製するためのプロセス
US7204981B2 (en) * 2000-03-28 2007-04-17 Eli Lilly And Company Methods of treating diseases with activated protein C
US20020045613A1 (en) * 2000-04-27 2002-04-18 Heinz Pauls 1-aroyl-piperidinyl benzamidines
GB0012362D0 (en) * 2000-05-22 2000-07-12 Aventis Pharma Ltd Chemical compounds
JP2004511428A (ja) 2000-05-24 2004-04-15 イーライ・リリー・アンド・カンパニー 凝固亢進状態を処置するための製剤および方法
BR0112631A (pt) 2000-07-20 2003-09-23 Neurogen Corp Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, pacote, métodos de reduzir a condutáncia de cálcio de um receptor de capsaicina e de tratar um mamìfero e uso de um composto
AU2003212882A1 (en) 2002-02-01 2003-09-02 Euro-Celtique S.A. 2 - piperazine - pyridines useful for treating pain
ATE416168T1 (de) 2002-02-15 2008-12-15 Glaxo Group Ltd Modulatoren des vanilloidrezeptors
EP1485121A4 (en) * 2002-03-08 2007-11-07 Lilly Co Eli ACTIVE C PROTEIN FORMULATIONS
ATE384698T1 (de) * 2002-06-28 2008-02-15 Euro Celtique Sa Therapeutische piperazin-derivate für die behandlung von schmerzen
US7262194B2 (en) * 2002-07-26 2007-08-28 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US7157462B2 (en) * 2002-09-24 2007-01-02 Euro-Celtique S.A. Therapeutic agents useful for treating pain
EP1627869B1 (en) * 2003-05-20 2012-05-02 Ajinomoto Co., Inc. Vanilloid receptor modulators
TWI287010B (en) * 2003-06-12 2007-09-21 Euro Celtique Sa Therapeutic agents useful for treating pain
EP1648879B1 (en) * 2003-07-24 2008-10-22 Euro-Celtique S.A. Heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain
JP4630871B2 (ja) * 2003-09-22 2011-02-09 ユーロ−セルティーク エス．エイ． 疼痛を治療するのに有用な治療薬
AU2004276251B2 (en) 2003-09-22 2008-02-07 Euro-Celtique S.A. Phenyl - carboxamide compounds useful for treating pain
TWI350168B (en) 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
WO2006002350A1 (en) * 2004-06-24 2006-01-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
WO2006012226A2 (en) 2004-06-24 2006-02-02 Incyte Corporation N-substituted piperidines and their use as pharmaceuticals
JP2008504280A (ja) * 2004-06-24 2008-02-14 インサイト・コーポレイション ２−メチルプロパンアミドおよびその医薬としての使用
CA2569507A1 (en) * 2004-06-24 2006-02-02 Incyte Corporation Amido compounds and their use as pharmaceuticals
CN101080226A (zh) * 2004-08-10 2007-11-28 因塞特公司 酰氨基化合物及它们作为药物的用途
US20060116382A1 (en) * 2004-11-10 2006-06-01 Wenqing Yao Lactam compounds and their use as pharmaceuticals
US8110581B2 (en) * 2004-11-10 2012-02-07 Incyte Corporation Lactam compounds and their use as pharmaceuticals
KR20070097441A (ko) * 2004-11-18 2007-10-04 인사이트 산 디에고 인코포레이티드 11-β 하이드록실 스테로이드 데하이드로게나제 유형 1의억제제 및 이를 사용하는 방법
BRPI0519288A2 (pt) 2004-12-24 2009-01-06 Astrazeneca Ab compostos heterocÍclicos como antagonistas de ccr2b
WO2007038138A2 (en) * 2005-09-21 2007-04-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
EP1957494A2 (en) * 2005-12-05 2008-08-20 Incyte Corporation Lactam compounds and methods of using the same
GB0525957D0 (en) 2005-12-21 2006-02-01 Astrazeneca Ab Methods
US7998959B2 (en) * 2006-01-12 2011-08-16 Incyte Corporation Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
KR20080091503A (ko) * 2006-01-31 2008-10-13 인사이트 코포레이션 아미도 화합물 및 약제로서의 이의 용도
TW200808807A (en) * 2006-03-02 2008-02-16 Incyte Corp Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
US20070208001A1 (en) * 2006-03-03 2007-09-06 Jincong Zhuo Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
WO2007130898A1 (en) * 2006-05-01 2007-11-15 Incyte Corporation TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1
WO2007137066A2 (en) * 2006-05-17 2007-11-29 Incyte Corporation HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
ES2293834B1 (es) * 2006-07-20 2009-02-16 Consejo Superior Investig. Cientificas Compuesto con actividad inhibidora de las interacciones ubc13-uev, composiciones farmaceuticas que lo comprenden y sus aplicaciones terapeuticas.
US8389549B2 (en) * 2007-04-27 2013-03-05 Purdue Pharma L.P. Substituted pyridines useful for treating pain
AU2011226773C1 (en) * 2007-04-27 2012-07-26 Purdue Pharma L.P. TRPV1 antagonists and uses thereof
JP5462784B2 (ja) * 2007-04-27 2014-04-02 パーデュー、ファーマ、リミテッド、パートナーシップ Ｔｒｐｖ１アンタゴニストとその使用
JP5520816B2 (ja) * 2007-05-04 2014-06-11 アストラゼネカ・アクチエボラーグ アミンおよびアミンオキシドで開始するアルキルホスフィン酸の合成方法
CL2008001839A1 (es) * 2007-06-21 2009-01-16 Incyte Holdings Corp Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
US7946206B2 (en) * 2007-11-21 2011-05-24 Rocksmart, Llc Quick-release system
KR20110098779A (ko) * 2008-12-03 2011-09-01 프레시디오 파마슈티칼스, 인코포레이티드 Ｈｃｖ ｎｓ5ａ의 억제제
US20100152197A1 (en) * 2008-12-15 2010-06-17 Astrazeneca Ab (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
EP2387567B1 (en) * 2009-01-14 2014-06-11 The Salk Institute for Biological Studies Compounds that protect against amyloid diseases
PL2723732T3 (pl) 2011-06-22 2017-07-31 Purdue Pharma Lp Antagoniści trpv1 z podstawnikiem dihydroksylowym oraz ich zastosowania
WO2013146969A1 (ja) * 2012-03-29 2013-10-03 第一三共株式会社 新規二置換シクロヘキサン誘導体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256812A (en) * 1989-01-31 1993-10-26 Hoffmann-La Roche Inc. Carboxamides and sulfonamides
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE69203797T2 (de) * 1991-06-11 1996-02-08 Ciba Geigy Ag Amidino-Verbindungen, ihre Herstellung und Verwendung als Arzneimittel.
DE4127404A1 (de) * 1991-08-19 1993-02-25 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9122016D0 (en) * 1991-10-16 1991-11-27 Glaxo Group Ltd Chemical compounds
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds
DE4303840A1 (de) * 1992-10-22 1994-08-11 Thomae Gmbh Dr K Aryliden-1-azacycloalkane und Arylalkyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
US5648368A (en) * 1992-12-01 1997-07-15 Merck & Co., Inc. Fibrinogen receptor antagonists

Also Published As

Publication number Publication date
EP0592949A2 (de) 1994-04-20
ZA937502B (en) 1995-04-11
US5442064A (en) 1995-08-15
CZ212893A3 (en) 1994-04-13
PL300673A1 (en) 1994-05-16
NZ248894A (en) 1996-01-26
NO180232B (no) 1996-12-02
NO933647D0 (no) 1993-10-11
AU668765B2 (en) 1996-05-16
MX9306303A (es) 1994-04-29
IL107221A0 (en) 1994-01-25
TW293815B (no) 1996-12-21
FI934460A0 (fi) 1993-10-11
CN1087904A (zh) 1994-06-15
KR940009164A (ko) 1994-05-20
EP0592949A3 (en) 1994-08-10
FI934460A7 (fi) 1994-04-13
JPH06199788A (ja) 1994-07-19
CA2108093A1 (en) 1994-04-13
SK107293A3 (en) 1994-08-10
AU4893993A (en) 1994-04-28
DE4234295A1 (de) 1994-04-14
NO180232C (no) 1997-03-12
HU9302875D0 (en) 1993-12-28

Similar Documents

Publication Publication Date Title
NO933647L (no) Karboksylsyrederivater, legemidler inneholdende disse og fremgangsmåte for deres fremstilling
NO934501D0 (no) Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmaat e for deres fremstilling
DK272389D0 (da) Anvendelse af gamma-hydroxysmoersyresalte til fremstilling af farmaceutiske praeparater til behandling af alkoholisme og praeparater opnaaet herved
NO930517D0 (no) Benzimidazolylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
FI884947A7 (fi) Tetrahydro-furo- ja -tieno/2,3-c/pyridiinit, niiden käyttö lääkeaineina ja menetelmä niiden valmistamiseksi
NO932120D0 (no) Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
DK346486D0 (da) Aminosalicylsyrederivater og farmaceutiske midler
NO892745D0 (no) Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling.
DK126888A (da) Bisphosphonsyrederivater og terapeutiske praeparater indeholdende disse forbindelser
DK435588D0 (da) Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse
DK0734382T3 (da) Krystallinske N-acetyl-neuraminsyrederivater og fremgangsmåder til deres fremstilling
DK241585A (da) 8-chlor-quinolincarboxylsyre-derivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende saadanne forbindelser
DK165006C (da) Kromoglycinsyrederivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
DK612788A (da) Alkoxyderivater af ginkolider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende saadanne forbindelser
DK712388D0 (da) Heterocyclisk substituerede oxo- eller thiophthalazinyl-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse
NO950665D0 (no) Nye polyjoderte forbindelser, fremgangsmåte for deres fremstilling og kontrastmidler inneholdende disse
DK587689A (da) 2-azabicyclo(2,2,1)hept-5-en-2-eddikesyre og derivater deraf, deres fremstilling og anvendelse
DK369088D0 (da) Fremgangsmaade til fremstilling af nukleinsyrederivater og fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende disse
DK155692D0 (da) Benzofuranylimidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse
DK463189D0 (da) 1,4-dihydropyridin-derivater, farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af antiallergiske og antiinflammatoriske laegemidler
DK488688A (da) Azolidindion-derivater og farmaceutiske praeparater indeholdende disse
DK454588A (da) Substituerede thienoimidazolderivater, deres fremstilling, farmaceutiske praeparater deraf og deres anvendelse som mavesyresekretionshaemmende midler
DK276690D0 (da) Selenophenderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK164913C (da) 5,6,7,8-tetrahydro-4h-isoxazol oe4,5-caa azepin-derivater, isomere og farmaceutisk acceptable syreadditionssalte deraf, fremgangsmaader til deres fremstilling, og farmaceutiske praeparater indeholdende disse forbindelser